Coordinating Clinical and Public Health Responses to Opioid Overdoses Treated in Emergency Departments
Joint Webinar – Vital Signs Town Hall Teleconference and COCA Call
Date: Tuesday, March 13, 2018
Time: 2:00-3:30 pm (Eastern Time)
Instructions for Obtaining Continuing Education (CE)
In order to receive continuing education (CE) for WC2922-031318 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Coordinating Clinical and Public Health Responses to Opioid Overdoses Treated in Emergency Departments – March 13, 2018, please visit TCEO and follow these 9 Simple Steps by April 16, 2018.
In order to receive continuing education (CE) for WD2922-031318 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Coordinating Clinical and Public Health Responses to Opioid Overdoses Treated in Emergency Departments – March 13, 2018 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by April 17, 2020
Join the 20th US Surgeon General, Acting CDC Director, a CDC subject matter expert, and other clinical and public health professionals for a webinar discussing new data and coordinated efforts by clinicians, public health government, and communities to respond to increasing opioid overdose emergency department visits. This combined webinar joins these two audiences together to provide a discussion on how clinicians and public health communities can work together in coordinating a more robust response to the opioid overdose epidemic.
The nonmedical use of prescription opioids and illicit opioids causes significant morbidity in the United States. The latest data indicate that rates of overdoses treated in emergency departments are rising across all regions and require a coordinated response between public health, clinicians, public safety, and community organizations.
During this call, clinicians and public health practitioners will learn about the increases in opioid-related morbidity and steps they can take together to reverse these trends.
At the conclusion of the session, the participant will be able to accomplish the following:
- Explain the latest epidemiological data around opioid-related morbidity within emergency departments.
- Describe ways that public health and emergency departments can collaborate to advance prevention and treatment efforts related to opioid overdoses.
- Identify steps that can be taken to establish protocols within emergency departments to prevent future opioid overdoses.
Call Slides: View Nowpdf icon
Webinar: Watch Nowmedia icon
Transcript: Read Now
Rear Admiral Anne Schuchat, MD (USPHS)(https://www.cdc.gov/about/leadership/director.htm)
Centers for Disease Control and Prevention (CDC)(https://www.cdc.gov/about/leadership/director.htm)
Vice Admiral Jerome M. Adams, MD, MPH (USPHS)(https://www.surgeongeneral.gov/about/biographies/bio-sg.html)external icon
20th Surgeon General of the United States
Alana Vivolo Kantor, PhD, MPH
Behavioral Health Scientist, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention (CDC)
Elizabeth Samuels, MD, MPH
Postdoctoral Fellow, Yale National Clinician Scholars Program, Implementation Lead for Levels of Care for Rhode Island Emergency Departments and Hospitals for Treating Overdose and Opioid Use Disorder
Meghan McCormick, MPH
Public Health Epidemiologist, Drug Overdose Prevention Program, Division of Community Health and Equity, Rhode Island Department of Health
- Webinar/Audio conference call on 3/13/2018: 2:00 – 3:30 PM ET
- Web-on-demand training after 3:30 PM ET on 3/13/2018
- Materials: PowerPoint slide set
Opioid Overdoses Treated in Emergency Departments: Identify opportunities for action
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses — United States, July 2016–September 2017
Annals of Emergency Medicine
Opportunities for Prevention and Intervention of Opioid Overdose in the Emergency Department
“WC2922” for attendees who participate in the live call (must be completed by April 16, 2018)
“WD2922” for attendees who participate in the online presentation (must be completed by April 17, 2020)
- Physician Assistants
- Health Educators
- State and Local Health Departments
- Other Public Health Practitioners
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-18-123-L04-P and enduring 0387-0000-18-123-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.